(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.59% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.87%.
Dentsply Sirona's revenue in 2025 is $3,671,000,000.On average, 9 Wall Street analysts forecast XRAY's revenue for 2025 to be $728,544,384,500, with the lowest XRAY revenue forecast at $721,732,609,098, and the highest XRAY revenue forecast at $734,479,627,816. On average, 9 Wall Street analysts forecast XRAY's revenue for 2026 to be $746,823,090,683, with the lowest XRAY revenue forecast at $730,110,931,260, and the highest XRAY revenue forecast at $765,359,729,499.
In 2027, XRAY is forecast to generate $768,743,374,749 in revenue, with the lowest revenue forecast at $744,473,769,252 and the highest revenue forecast at $791,492,115,290.